LEXARIA BIOSCIENCE CORP. (LEXX)

Import this data to Google Sheets with:

=jivedata("LEXX","financials")

Full statements spill as a table. For one cell: =jivedata("LEXX","Revenue") or =jivedata("LEXX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

LEXARIA BIOSCIENCE CORP.

LEXX • CIK 0001348362

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$226.208	$464.278	$705.923	$194
Cost of Goods and Services Sold	$31.5	$4.822	$2.72	$0
Gross Profit	$194.708	$459.456	$703.203	$194
Net Income (Loss) Attributable to Parent	$-6,664.899	$-5,795.345	$-11,901.841	$-7,732.026
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	—	$-5,815.161	$-11,952.36	$-7,697.426
Weighted Average Number of Shares Outstanding, Diluted	—	12,383,974	17,998,715	24,069,149
Research and Development Expense	$3,666.721	$2,360.565	$8,238.757	$3,999.682
General and Administrative Expense	$3,062.009	$3,852.021	$4,345.183	$3,902.253
Operating Expenses	$6,728.73	$6,212.586	$12,583.94	$7,901.935
Operating Income (Loss)	$-6,534.022	$-5,753.13	$-11,880.737	$-7,707.935
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	—	—	$-50.519	$62.802
Interest Income, Other	$43.19	$14.117	$3.017	$5.434
Marketable Securities, Unrealized Gain (Loss)	$-221.693	$-69.835	$-33.714	$-33.54
Nonoperating Income (Expense)	—	—	$-30.697	$-28.106
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-6,712.525	$-5,808.654	$-11,911.434	$-7,740.444
Net Income (Loss) Attributable to Noncontrolling Interest	$-47.626	$-13.309	$-9.593	$-8.418

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$1,352.102	$6,499.885	$1,802.123	$3,475.003
Other Short-term Investments	—	—	$143.267	$143.267
Marketable Securities, Current	$125.642	$55.807	$22.093	$0
Accounts Receivable, after Allowance for Credit Loss, Current	$175.245	$154.477	$368.358	$48.998
Prepaid Expense and Other Assets, Current	—	$1,187.817	$1,132.504	$398.765
Assets, Current	$2,199.772	$7,897.986	$3,468.345	$4,064.869
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$167.446	$134.843	$106.816	$92.018
Other Indefinite-lived Intangible Assets	—	—	$307.818	$318.058
Property, Plant and Equipment, Net	$254.143	$254.709	$228.129	$229.017
Assets, Noncurrent	$884.214	$969.803	$706.776	$716.462
Assets	$3,083.986	$8,867.789	$4,175.121	$4,781.331
Operating Lease, Liability, Current	—	—	$30.417	$33.035
Liabilities, Current	$267.735	$1,099.419	$1,493.463	$383.412
Operating Lease, Liability, Noncurrent	—	—	$78.903	$53.679
Liabilities	$403.908	$1,208.738	$1,572.366	$437.091
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$2,680.078	$7,659.051	$2,602.755	$4,344.24
Long-term Investments and Receivables, Net	—	$63.575	$64.013	$64.014
Accounts Payable and Accrued Liabilities, Current	$239.941	$1,066.409	$1,463.046	$350.377
Deferred Revenue, Current	—	—	$0	$0
Common Stock, Value, Issued	$8.091	$15.81	$19.559	$24.788
Additional Paid in Capital	$48,799.454	$59,599.178	$66,501.086	$73,256.696
Retained Earnings (Accumulated Deficit)	$-45,763.427	$-51,558.772	$-63,460.613	$-68,496.801
Accumulated Other Comprehensive Income (Loss), Net of Tax	—	$-19.816	$-70.335	$-46.473
Stockholders' Equity Attributable to Parent	$3,044.118	$8,036.4	$2,989.697	$4,738.21
Common Stock, Shares Authorized	220,000,000	220,000,000	220,000,000	220,000,000
Common Stock, Shares, Issued	8,091,650	15,810,205	19,559,179	24,787,446

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	—	$-50.519	$34.6
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	—	$5,147.783	$-4,697.762	$-1,116.758
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$1,352.102	$6,499.885	$1,802.123	$-1,994.898
Share-based Payment Arrangement, Noncash Expense	$170.382	$492.236	$859.494	$365.458
Depreciation, Depletion and Amortization, Nonproduction	$145.397	$76.153	$87.825	$76.573
Payments to Acquire Intangible Assets	$135.862	$145.591	$75.106	$61.055
Impairment of Intangible Assets, Finite-lived	—	—	$247.364	$213.824
Payments to Acquire Property, Plant, and Equipment	$33.748	$43.014	$24.646	$40.817
Accounts Receivable, Credit Loss Expense (Reversal)	—	—	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-169.61	$-188.605	$-243.019	$-243.975
Other Noncash Expense	—	—	$28.027	$29.6
Marketable Securities, Unrealized Gain (Loss)	$-221.693	$-69.835	$-33.714	$-33.54
Accretion Expense	—	—	$9.047	$7.473
Proceeds from Issuance of Common Stock	—	—	$6,046.163	$6,518.105
Net Cash Provided by (Used in) Financing Activities	$1,589.731	—	$6,046.163	$6,518.105
Increase (Decrease) in Accounts Receivable	$26.539	$35.551	$213.881	$-309.131
Increase (Decrease) in Prepaid Expense and Other Assets	—	—	$-55.313	$-424.583
Increase (Decrease) in Long-term Receivables, Current	—	—	$0.438	$0
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$88.492	$826.468	$396.637	$-1,107.882
IncreaseDecreaseInOperatingLeaseLiability	$-44.814	$-33.273	$-37.093	$-37.345
Increase (Decrease) in Deferred Revenue	—	$4.962	$-4.962	$0.001
Net Cash Provided by (Used in) Operating Activities	$-5,881.237	$-4,959.003	$-10,450.387	$-7,425.488

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("LEXX","financials")

Full statements spill as a table. For one cell: =jivedata("LEXX","Revenue") or =jivedata("LEXX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.